عرض بسيط للتسجيلة

المرشدAl-Badriyeh, Daoud
المؤلفALHERSH, EILAN
تاريخ الإتاحة2021-07-06T05:38:43Z
تاريخ النشر2021-06
معرّف المصادر الموحدhttp://hdl.handle.net/10576/21218
الملخصObjective: This thesis sought to evaluate the cost effectiveness of high dose (HD) caffeine as alternative therapy over the standard low dose (LD) caffeine for apnea of prematurity (AOP) in neonates, in Hamad Medical Corporation (HMC), Qatar. Methods: A decision-analytic, literature-based, economic simulation model was constructed, from the hospital perspective, to evaluate high (20 mg/kg/dose) versus low (10 mg/kg/dose) maintenance caffeine doses as first-line therapy for AOP. The clinical data inputs were obtained from best available meta-analysis identified from systematic review conducted for this purpose. The cost model inputs were HMC based. Therapy success was defined as survival with <3 apnea episodes per day and successful extubation removal, with/without adverse events. Results: With 0.23 (95% CI, 0.23-0.23) enhancement in success rate, at QAR 14,084 (95% CI, 13,916-14,251) added patient cost, the HD caffeine costed QAR 61,500 (95% CI, 55,480-67,520) over LD caffeine per additional case of success. Sensitivity analyses confirmed the study robustness. Conclusion: For AOP, based on the willingness-to-pay threshold, HD caffeine seems to be a cost-effective alternative to LD caffeine in HMC.
اللغةen
الموضوعcaffeine
Intensive Care Unit
Apnea in Neonatal
neonates
Hamad Medical Corporation (HMC)
العنوانA COST-EFFECTIVENESS ANALYSIS FOR HIGH VERSUS LOW DOSE CAFFEINE FOR THE TREATMENT OF APNEA IN NEONATAL INTENSIVE CARE UNIT
النوعMaster Thesis
التخصصPharmacy
dc.accessType Abstract Only


الملفات في هذه التسجيلة

الملفاتالحجمالصيغةالعرض

لا توجد ملفات لها صلة بهذه التسجيلة.

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة